Navigation Links
MAP Pharmaceuticals Reports Third Quarter of 2008 Financial Results
Date:11/12/2008

e in sales, general and administrative expenses for the nine months ended September 30, 2008 as compared to the same period in 2007 was primarily related to increases in personnel related expenses and stock-based compensation, as well as increases due to professional fees, outside services and other administrative related costs, partially offset by a decrease in non-recurring IPO expenses incurred in the prior year.

MAP Pharmaceuticals had cash, cash equivalents and short-term investments as of September 30, 2008 of $63.0 million, compared to $95.0 million as of December 31, 2007. In addition, for the three and nine months ended September 30, 2008, non-cash share-based compensation and depreciation was approximately $1.5 million and $4.0 million, respectively.

About MAP Pharmaceuticals, Inc.

MAP Pharmaceuticals is dedicated to developing and commercializing new therapies for children and adults suffering from chronic conditions that are not adequately treated by currently available medicines. The company has two product candidates in Phase 3 clinical trials. Unit Dose Budesonide is being developed for the potential treatment of pediatric asthma, and MAP0004 is being developed for the potential treatment of migraine. MAP Pharmaceuticals generates new pipeline opportunities by applying its proprietary drug particle and inhalation technologies to enhance the therapeutic benefits of proven drugs, while minimizing risk, by capitalizing on their known safety, efficacy and commercialization history.

Additional information about MAP Pharmaceuticals can be found at http://www.mappharma.com.

Forward-Looking Statements

In addition to statements of historical facts or statements of current conditions, this press release contains forward-looking statements, including with respect to MAP Pharmaceuticals' late stage clinical programs. Actual results may differ materially from current exp
'/>"/>

SOURCE MAP Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. Ferring Pharmaceuticals Promotes William Garbarini to Vice President of New Orthopaedics and Urology Business Unit
2. Alexza Pharmaceuticals Announces Upcoming Conference Participation and Webcasts
3. Jazz Pharmaceuticals, Inc. to Announce Third Quarter Financial Results on November 13, 2008
4. Keryx Biopharmaceuticals, Inc. Announces Third Quarter 2008 Financial Results
5. MAP Pharmaceuticals to Present at the Lazard Capital Markets 5th Annual Healthcare Conference
6. Keryx Biopharmaceuticals KRX-0401 (Perifosine) Data Selected for Oral Presentation at the 50th Annual Meeting of the American Society of Hematology
7. Duska Therapeutics and DSM Pharmaceuticals in Manufacturing Collaboration for PSVT Drug Product
8. Memory Pharmaceuticals Announces Six Abstracts Accepted for Presentation at Society for Neuroscience Meeting
9. Alseres Pharmaceuticals, Inc. To Host Third Quarter 2008 Conference Call
10. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Third Quarter 2008 Financial Results on Tuesday, November 11, at 8:30 A.M. EST
11. Sagent Pharmaceuticals Announces Presentations at Upcoming Lazard Capital Markets and Piper Jaffray Healthcare Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2015)... (PRWEB) , ... August 30, 2015 , ... Rio ... O’Shea to serve as the college’s Vice President of Strategic Initiatives and Information Services. ... eager to help the college expand its reach and impact through innovative technologies and ...
(Date:8/29/2015)... PITTSBURGH, PA (PRWEB) , ... August 29, 2015 ... ... 1996," said one of two inventors from Miller Place, N.Y. "I specialize in ... pain and discomfort. In addition, it can be used for additional muscle dysfunction ...
(Date:8/29/2015)... ... , ... Brands like Toppik , Eau Thermale Avene and Bliss are ... threshold of $49.00 was required to qualify for free standard shipping,” said Jennifer Ramirez, ... for customers regardless of the item’s selling price.” , With competitive pricing in the ...
(Date:8/29/2015)... ... August 29, 2015 , ... Hamstring strain ... stretching, soft tissue manipulation. Platelet rich plasma injections also have mixed results. ... improve treatment outcomes. This localized treatment seems to address the symptoms and ...
(Date:8/28/2015)... , ... August 28, 2015 , ... ... center management, Decatur County Memorial Hospital recently transitioned management companies to partner with ... Center Management for their outpatient wound center. , Transitioning wound care management ...
Breaking Medicine News(10 mins):Health News:Rio Salado College Appoints New Vice President of Strategic Initiatives and Information Services 2Health News:Inventors and InventHelp Clients Develops Tension Reliever (LGI-1951) 2Health News:TheBeautyPlace.com Discounts Shipping on Select Brands 2Health News:NEW APPROACH for Treatment of Recurrent Hamstring Strains and Hamstring Tendinosis is Available for the First Time in NYC 2Health News:NEW APPROACH for Treatment of Recurrent Hamstring Strains and Hamstring Tendinosis is Available for the First Time in NYC 3Health News:Decatur County Memorial Hospital Transitions Wound Center Management To Wound Care Advantage and the Luvo Operating System 2Health News:Decatur County Memorial Hospital Transitions Wound Center Management To Wound Care Advantage and the Luvo Operating System 3Health News:Decatur County Memorial Hospital Transitions Wound Center Management To Wound Care Advantage and the Luvo Operating System 4
... of Experimental Medicine -, - Findings Underscore Versatility ... Antagonists as Possible ... TorreyPines Therapeutics, Inc.,(Nasdaq: TPTX ) today announced ... Hopkins University (JHU) for intellectual property,related to the novel ...
... Blue Cross and Blue Shield of,Florida ... been appointed Market,President - West Florida, effective ... (Logo: http://www.newscom.com/cgi-bin/prnh/20000427/BLUELOGOA ), ... has served in a number of leadership ...
... May 1 Cadient Group, the,premier strategic interactive ... has appointed Barbara Dowling as Senior Vice,President, Customer ... on both the client and agency side, Barb ... to address business critical,issues. In this role, Dowling ...
... 1 Nu Skin Enterprises, Inc.,(NYSE: NUS ... a 9,percent improvement over the prior-year period. Earnings ... 31 percent increase compared to the same,quarter of ... 6 percent,by foreign currency fluctuations. Quarterly earnings per ...
... Calif., May 1 Cardiogenesis,Corporation (Pink Sheets: CGCP), ... first quarter ended March 31, 2008 prior to ... also said that President Richard P.,Lanigan and Senior ... will host an investor conference call that day ...
... Performs with Peerless Safety and Proven Efficacy in all Four ... Chambers of the Heart, Stereotaxis to Introduce ... ... May 1 Stereotaxis, Inc. (Nasdaq:,STXS), announced today that approximately 15,000 procedures have been,performed ...
Cached Medicine News:Health News:TorreyPines Therapeutics Licenses Intellectual Property from Johns Hopkins Related to Novel Uses of Glutamate Receptor Antagonists for Prevention, Treatment of Stroke, Heart Attack 2Health News:TorreyPines Therapeutics Licenses Intellectual Property from Johns Hopkins Related to Novel Uses of Glutamate Receptor Antagonists for Prevention, Treatment of Stroke, Heart Attack 3Health News:TorreyPines Therapeutics Licenses Intellectual Property from Johns Hopkins Related to Novel Uses of Glutamate Receptor Antagonists for Prevention, Treatment of Stroke, Heart Attack 4Health News:David Pizzo Appointed Blue Cross and Blue Shield of Florida Market President - West Florida 2Health News:Cadient Group Appoints Barbara Dowling to Senior Vice President Customer Engagements 2Health News:Nu Skin Enterprises Reports First-Quarter 2008 Results 2Health News:Nu Skin Enterprises Reports First-Quarter 2008 Results 3Health News:Nu Skin Enterprises Reports First-Quarter 2008 Results 4Health News:Nu Skin Enterprises Reports First-Quarter 2008 Results 5Health News:Nu Skin Enterprises Reports First-Quarter 2008 Results 6Health News:Nu Skin Enterprises Reports First-Quarter 2008 Results 7Health News:Nu Skin Enterprises Reports First-Quarter 2008 Results 8Health News:Nu Skin Enterprises Reports First-Quarter 2008 Results 9Health News:Nu Skin Enterprises Reports First-Quarter 2008 Results 10Health News:Stereotaxis Niobe Magnetic Navigation Systems Perform Approximately 15,000 Cases 2Health News:Stereotaxis Niobe Magnetic Navigation Systems Perform Approximately 15,000 Cases 3Health News:Stereotaxis Niobe Magnetic Navigation Systems Perform Approximately 15,000 Cases 4
(Date:8/28/2015)... , August 28, 2015 ... Market by Tumor (Breast, Lung, Prostate) Type (Protein & ... (Diagnostic, Drug Discovery, Prognostic) & Geography - Global Forecast ... is expected to reach around 17,689.0 Million USD by ... period of 2015 to 2020. Browse ...
(Date:8/28/2015)... Utah , Aug. 28, 2015  Today, in ... Prevention,s (CDC) Contact Lens Health Week, 1-800 Contacts is ... has found that contact lens wearers who do not ... greatest risk for eye infections. Most ... their lenses, but a clean lens case is sometimes ...
(Date:8/28/2015)... , Aug. 28, 2015 ... addition of the "Investigation Report on China,s Ranibizumab ... Developed by Novartis, ranibizumab was approved by CFDA to ... Currently, only Lucentis, a product of Novartis, is available ... the first self- developed drug for the treatment of ...
Breaking Medicine Technology:Cancer Biomarkers Market Worth 17,689.0 Million USD by 2020 2Cancer Biomarkers Market Worth 17,689.0 Million USD by 2020 3Cancer Biomarkers Market Worth 17,689.0 Million USD by 2020 4Cancer Biomarkers Market Worth 17,689.0 Million USD by 2020 51-800 Contacts Shares Tips on How to Clean Lens Cases 2Investigation Report on China's Ranibizumab Market, 2012-2019 2
... DIEGO, Nov. 24 Anadys Pharmaceuticals, Inc. (Nasdaq: ANDS ... Annual Piper Jaffray Healthcare Conference on Tuesday, December 1, 2009 ... is being held at The New York Palace Hotel. ... will provide an overview of Anadys and its clinical development ...
... , POTOMAC, Md., Nov. 24 In ... has added Philadelphia jurors to her Thanksgiving gratitude list. ... I am so thankful to them," she said of Monday,s ... , Wisneski is among 12,000 women nationwide who have sued ...
Cached Medicine Technology:Anadys Pharmaceuticals to Present at the Piper Jaffray Healthcare Conference 2Maryland Woman Thankful for Wyeth Verdicts 2
An indirect immunofluorescence (IFA) antibody test for the detection and semiquantitation of anti-glomerular basement membrane (GBM) antibodies in human serum. Slide Detail: 6-well Monkey Kidney Subs...
An enzyme linked immunosorbant assay (ELISA) for the detection and quantitation of Rheumatoid Factor (RF) IgA isotype in human serum....
An enzyme linked immunoassay (ELISA) for the detection and semiquantitation of IgG, IgA or IgM anticardiolipin antibodies, as an aid in assessing the risk of thrombosis in individuals with Systemic L...
The ImagingPlanet 70 mm surgical microscope video adapter: Superior optical quality and precise engineering make this 70 mm focal length adapter an excellent decision for use with your Leica surgica...
Medicine Products: